1Olthoff KM, Judge TA, Gelmen AE et al. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat Med, 1998, 4:194.
2Liu CY, Deng S, Yang Z et al. Local production of CTLA4Ig by adeno viral mediated gene transfer to the pancreas induced permanent allograft survival and donor-specific tolerance. Transplant Proc, 1999, 31: 625.
3Qin L, Chavin KD, Ding Y et al. Retrovirus mediated gene transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol,1996, 156:2316.
4Zuo XJ, Charles Wang, Dale Carpenter et al. Prolongation of allograft survival with viral IL-10 transplantation in a highly histomcompatible model of rat heart allograft rejection. Transplantation, 2001, 71: 686.
5Chahine A, Yu M, McKeman M et al. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells. Transplantation, 1995, 59:1313.
6Lau H, Yu M, Fontana A et al. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science, 1996, 273:109.
7Kang SM, Schneider DB, 1in Z et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med, 1997, 3:738.
8Allison J, Harry MG, Andreas S et al. Transgenic expression of CD95 ligand on islet cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA, 1997,94: 3943.
9Simons M, Elazer RE, Jean-Luc D et al. Antisense c-myb oligonucleoti des inhibit intimal arterial smooth muscle accumulation in vivo. Nature,1992, 359:67.
10Ohno T, Gordon D, San H etal. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science, 1992, 257:792.
